Philip Morris/$PM
1D1W1MYTD1Y5YMAX
Capital at risk
About Philip Morris
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI is not only dominant in smokable products but also has the Iqos and Zyn brands, which respectively dominate heated tobacco and nicotine pouches in most markets. It also owns the Veev brand in vapes.
- Ticker
- $PM
- Sector
- Consumer Essentials
- Primary listing
- NYSE
- Employees
- 84,900
- Headquarters
- Stamford, United States
- Website
- www.pmi.com
Philip Morris Metrics
BasicAdvanced
$288B
26.58
$6.95
0.40
$5.88
3.18%
Price and volume
Market cap
$288B
Beta
0.4
52-week high
$207.76
52-week low
$142.11
Average daily volume
4.5M
Dividend rate
$5.88
Financial strength
Current ratio
0.98
Quick ratio
0.47
Long term debt to equity
-636.743
Total debt to equity
-738.155
Dividend payout ratio (TTM)
82.82%
Interest coverage (TTM)
10.40%
Profitability
EBITDA (TTM)
19,918
Gross margin (TTM)
67.48%
Net profit margin (TTM)
25.56%
Operating margin (TTM)
37.53%
Effective tax rate (TTM)
21.10%
Revenue per employee (TTM)
$500,000
Management effectiveness
Return on assets (TTM)
16.33%
Return on equity (TTM)
-137.14%
Valuation
Price to earnings (TTM)
26.58
Price to revenue (TTM)
6.76
Price to book
-33.55
Price to tangible book (TTM)
-8.07
Price to free cash flow (TTM)
22.608
Free cash flow yield (TTM)
4.42%
Free cash flow per share (TTM)
8.171
Dividend yield (TTM)
3.18%
Forward dividend yield
3.18%
Growth
Revenue change (TTM)
8.93%
Earnings per share change (TTM)
31.84%
3-year revenue growth (CAGR)
8.65%
10-year revenue growth (CAGR)
5.03%
3-year earnings per share growth (CAGR)
10.37%
10-year earnings per share growth (CAGR)
5.22%
3-year dividend per share growth (CAGR)
5.00%
10-year dividend per share growth (CAGR)
3.72%
What the Analysts think about Philip Morris
Analyst ratings (Buy, Hold, Sell) for Philip Morris stock.
Analyst projections of the future price of Philip Morris stock.
Bulls say / Bears say
Higher cigarette demand helped Philip Morris beat Q2 2026 estimates, leading management to increase investment in its Zyn nicotine pouches to capture growth in the category (Reuters)
The U.S. FDA granted modified risk tobacco product authorization to 20 variants of Zyn nicotine pouches on June 30, 2026, allowing marketing as less harmful than cigarettes and reinforcing PMI’s regulatory advantage in reduced-risk products (Reuters)
Philip Morris reaffirmed its 2026 adjusted EPS guidance of $8.26–$8.41 and organic net revenue growth target of 5%–7% following a robust first half, reflecting management’s confidence in its growth trajectory (Reuters)
PMI expects a non-cash impairment charge of approximately $500 million related to its Canadian affiliate RBH in Q2 2026, reducing GAAP EPS by $0.33 per share (Reuters)
On June 2, 2026, Philip Morris International cut its full-year 2026 adjusted EPS guidance to $8.31–$8.46 from $8.36–$8.51, citing currency volatility and cost pressures (Reuters)
The company anticipates full-year cigarette shipment volumes will decline by 2%–3%, underscoring a structural downturn in its core combustible business (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 24 Aug 2026.
Philip Morris Financial Performance
Revenues and expenses
Philip Morris Earnings Performance
Company profitability
Upcoming events
No upcoming events
Philip Morris News
AllArticlesVideos
Funds containing Philip Morris
AllEURGBPUSD
Fund name | Fund size | $PM weighting |
|---|---|---|
iShares S&P 500 Consumer Staples Sector€2B7D | €450M | 10.13% |
iShares S&P 500 Consumer Staples Sector£ICSU | £386M | 10.13% |
iShares Edge S&P 500 Minimum Volatility$SPMV | $1.9B | 1.62% |
iShares Edge S&P 500 Minimum Volatility€IBCK | €1.6B | 1.62% |
iShares Edge S&P 500 Minimum Volatility£MVUS | £1.4B | 1.62% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.